Skip to main content
SpringerLink
Log in

Commonly Asked Questions

  • Chapter
  • First Online:
Towards Optimal Management of Diabetes in Surgery

  • 391 Accesses

Abstract

Q1: What are the abnormalities/mechanisms which result in type 2 diabetes?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

References on Q4: You have mentioned the Leuven studies. Their results are not confirming but often contradictory. How do you explain that?

  1. Berghe G, Dodek P. Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med. 2001;29:1714–9.

    Article  Google Scholar 

  2. Van den Berghe G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–61.

    Article  Google Scholar 

  3. The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575–85, nejm.org. 29 Apr 2010.

    Article  Google Scholar 

  4. Van den Berghe, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–9.

    Article  Google Scholar 

References on Q8: Type 2 diabetes needs many drugs for normoglycemia and many more to control other complications. Are there any significant drug interactions?

  1. Scheen Andre J. Drug interactions of clinical importance with antihyperglycemic agents an update. Drug Saf. 2005;28(7):601–31.

    Article  Google Scholar 

  2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.

    Article  Google Scholar 

  3. Surekha V, Peter JV, Jeyaseelan L, et al. Drug interaction: rifampicin and glibenclamide. Natl Med J India. 1997;10:11–2.

    CAS  PubMed  Google Scholar 

References for Q9: What are the indications, contraindications, advantages, disadvantages, and side effects of total parenteral nutrition (TPN)? How is glycemic control affected and how is it managed?

  1. Alberti KG, Marshall SM. Diabetes and surgery. In: Alberti KG, Krall LP, editors. Diabetes annual/4. New York: Elsevier; 1988. p. 248–71.

    Google Scholar 

  2. Ziegler TR. Parenteral nutrition in the critically ill patient. N Engl J Med. 2009;361:1088–97. [PubMed: 19741230].

    Article  CAS  Google Scholar 

  3. McMahon MM, Rizza RA. Nutrition support in the hospitalized patient with diabetes mellitus. Mayo Clinic Proc. 1996;71:587–94.

    Article  CAS  Google Scholar 

  4. Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ, Hoogwerf BJ, Lichtenstein AH, Mayer-Davis E, Mooradian AD, Wheeler ML. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31(Suppl 1):S61–78. https://doi.org/10.2337/dc08-S061.2008.

    Article  CAS  PubMed  Google Scholar 

  5. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009;33:277–316.

    Article  Google Scholar 

  6. Mesotten D, Gielen M, Wouters PJ, Desmet L, Vlasselaers D, Vanhorebeek I, Langouche L, Van den Berghe G. Effect of tight glucose control with insulin on the thyroid axis of critically ill children and its relation with outcome. J Clin Endocrinol Metab. 2012;97(10):3569–76. https://doi.org/10.1210/jc.2012-2240. Epub 2012 Aug 7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Van den Berghe G, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55:3151–9.

    Article  Google Scholar 

  8. van Den Berghe G, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003;31(2):359–66.

    Article  Google Scholar 

  9. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009;15:353–69. [PubMed: 19454396].

    Article  Google Scholar 

  10. Rosmarin DK, Wardlaw GM, Mirtallo J. Hyperglycemia associated with high, continuous infusion rates of total parenteral nutrition dextrose. Nutr Clin Pract. 1996;11:151–6. [PubMed: 9070016].

    Article  CAS  Google Scholar 

  11. McCowen KC, Bistrian BR. Hyperglycemia and nutrition support: theory and practice. Nutr Clin Pract. 2004;19:235–44. [PubMed: 16215111].

    Article  Google Scholar 

  12. Ahrens CL, Barletta JF, Kanji S, et al. Effect of low-calorie parenteral nutrition on the incidence and severity of hyperglycemia in surgical patients: a randomized, controlled trial. Crit Care Med. 2005;33:2507–12. [PubMed: 16276174].

    Article  CAS  Google Scholar 

  13. Schutz Y, Thiebaud D, Acheson KJ, et al. Thermogenesis induced by five different intravenous glucose/insulin infusions in healthy young men. Clin Nutr. 1983;2:93–6. [PubMed: 16829417].

    Article  CAS  Google Scholar 

  14. Askanazi J, Weissman C, Rosenbaum SH, et al. Nutrition and the respiratory system. Crit Care Med. 1982;10:163–72. [PubMed: 6800701].

    Article  CAS  Google Scholar 

  15. Casaer MP, Mesotten D, Hermans G, et al. Early vs late parenteral nutrition in critically ill adults. N Engl J Med. 2011;365:506–17. [PubMed: 21714640].

    Article  CAS  Google Scholar 

  16. Lidder P, Flanagan D, Fleming S, et al. Combining enteral with parenteral nutrition to improve postoperative glucose control. Br J Nutr. 2010;103:1635–41. [PubMed: 20211036].

    Article  CAS  Google Scholar 

  17. Singer P, Berger MM, Van den Berghe G, et al. ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr. 2009;28:387–400. [PubMed: 19505748].

    Article  Google Scholar 

  18. Via MA, Mechanick JI. Inpatient enteral and parental nutrition for patients with diabetes. Curr Diab Rep. 2011;11:99–105. [PubMed: 21170688].

    Article  CAS  Google Scholar 

  19. Gosmanov AR, Umpierrez GE. Medical nutrition therapy in hospitalized patients with diabetes. Curr Diab Rep. 2012;12:93–100. [PubMed: 21997598].

    Article  CAS  Google Scholar 

  20. Yaqoob P. Lipids and the immune response. Curr Opin Clin Nutr Metab Care. 1998;1:153–61. [PubMed: 10565342].

    Article  CAS  Google Scholar 

  21. Yaqoob P. Monounsaturated fatty acids in parenteral nutrition; evaluation of risks and benefits. Br J Nutr. 2005;94:867–8. [PubMed: 16351759].

    Article  CAS  Google Scholar 

  22. Buenestado A, Cortijo J, Sanz MJ, et al. Olive oil-based lipid emulsion’s neutral effects on neutrophil functions and leukocyte-endothelial cell interactions. JPEN J Parenter Enteral Nutr. 2006;30:286–96.

    Article  CAS  Google Scholar 

  23. Garcia-de-Lorenzo A, Denia R, Atlan P, et al. Parenteral nutrition providing a restricted amount of linoleic acid in severely burned patients: a randomized double-blind study of an olive oil-based lipid emulsion vs medium/long-chain triacylglycerols. Br J Nutr. 2005;94:221–30. [PubMed: 16115356].

    Article  CAS  Google Scholar 

  24. Siqueira J, Smiley D, Newton C, et al. Substitution of standard soybean oil with olive oil-based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects. J Clin Endocrinol Metab. 2011;96:3207–16. [PubMed: 21832112].

    Article  CAS  Google Scholar 

  25. Umpierrez GE, Spiegelman R, Zhao V, et al. A double-blind, randomized clinical trial comparing soybean oil-based vs olive oil-based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med. 2012;40:1792–8. [PubMed: 22488002].

    Article  CAS  Google Scholar 

  26. Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28:2367–71. [PubMed: 16186264].

    Article  Google Scholar 

  27. Pasquel FJ, Spiegelman R, McCauley M, et al. Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care. 2010;33:739–41. [PubMed: 20040658].

    Article  Google Scholar 

  28. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications of total parenteral nutrition. Gastroenterology. 1993;104:286–301. [PubMed: 8419252].

    Article  CAS  Google Scholar 

  29. Sajbel TA, Dutro MP, Radway PR. Use of separate insulin infusions with total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1987;11:97–9.

    Article  CAS  Google Scholar 

  30. Hongsermeier T, Bistrian BR. Evaluation of a practical technique for determining insulin requirements in diabetic patients receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1993;17:16–9.

    Article  CAS  Google Scholar 

  31. Valero MA, Leon-Sanz M, Escobar I, et al. Evaluation of non-glucose carbohydrates in parenteral nutrition for diabetic patients. Eur J Clin Nutr. 2001;55:1111–6. [PubMed: 11781679].

    Article  CAS  Google Scholar 

  32. Jakoby MG, Nannapaneni N. An insulin protocol for management of hyperglycemia in patients receiving parenteral nutrition is superior to ad hoc management. JPEN J Parenter Enteral Nutr. 2012;36:183–8.

    Article  CAS  Google Scholar 

  33. Sarkisian S, Fenton TR, Shaheen AARaman M, Raman M. Parenteral nutrition-associated hyperglycemia in noncritically ill inpatients is associated with higher mortality. Canadian journal of gastroenterology. J Can Gastroenterol. 2010;24:453–7. [PubMed: 20652162].

    Article  Google Scholar 

References for Q10: How has the Alberti regime evolved over years? Its transition to the insulin infusion through to the Syringe pump needs more clarification

  1. Milaskiewicz RM, Hall GM. Diabetes and anaesthesia: the past decade. Br J Anaesth. 1992;68(2):198–206.

    Article  CAS  Google Scholar 

  2. Eldridge AJ, Sear JW. Peri-operative management of diabetic patients. Any changes for the better since 1985? Anaesthesia. 1996;51:45–51.

    Article  CAS  Google Scholar 

  3. Achinger SG, Ayus JC, Moritz ML. Dysnatremias: why are patients still dying? South Med J. 2006;4:353–62.

    Article  Google Scholar 

  4. Grant IS, Nimmo GR, Nimmo S. Intercurrent disease and anaesthesia. In: Aitkenhead AR, Smith G, Rowbotham DJ, editors. Textbook of anaesthesia. Oxford: Churchill Livingstone Elsevier; 2007. p. 466–8.

    Google Scholar 

References for Q17: Are there formulae to calculate insulin doses while converting a patient on IV insulin to subcutaneous insulin?

  1. Donaldson S, Villanuueva G, Rondinelli L, Baldwin D. Rush University guidelines and protocols for the management of hyperglycemia in hospitalized patients: elimination of the sliding scale and improvement of glycemic control throughout the hospital. Diabetes Educ. 2006;32:954–62.

    Article  Google Scholar 

  2. Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol. 2006;98:557–64.

    Article  CAS  Google Scholar 

  3. O’Malley CW, Emanuele M, Halasyamani L, Amin AN. Bridge over troubled waters: safe and effective transitions of the inpatient with hyperglycemia. J Hosp Med. 2008;3:55–65.

    Article  Google Scholar 

  4. Ramos P, Childers D, Maynard G, et al. Maintaining glycemic control when transitioning from infusion insulin: a protocol driven, multidisciplinary approach. J Hosp Med. 2010;5:446–51.

    Article  Google Scholar 

  5. Avanzini F, Marelli G, Donzelli W, et al. Transition from intravenous to subcutaneous insulin: effectiveness and safety of a standardized protocol and predictors of outcome in patients with acute coronary syndrome. Diabetes Care. 2011;34:1445–50.

    Article  CAS  Google Scholar 

  6. Magaji V, Johnston J. Inpatient management of hyperglycemia and diabetes. Clin Diab. 2011;29:3–9.

    Article  Google Scholar 

Additional Reading

  • Australian Diabetes Educators Association. Sick day management of adults with type 2 diabetes. Canberra: ADEA; 2014.

    Google Scholar 

  • Robins M, Coles M, Smith D, Armstrong M, Bryant W, Homeming L, on behalf of the Australian Diabetes Educators Association. Clinical guiding principles for sick day management of adults with type 1 and type 2 diabetes. Technical document. Canberra: ADEA; 2014.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Private Practice, Pune, Maharashtra, India

    Sanjeev Kelkar

  2. Senior Consultant Anesthesiologist, Central India Institute of Medical Science, Nagpur, Maharashtra, India

    Shubhangi Muley

  3. Consultant, Anesthesioligist, Fortis S L Raheja Hospital, Mumbai, Maharashtra, India

    Prakash Ambardekar

Authors
  1. Sanjeev Kelkar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shubhangi Muley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Prakash Ambardekar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kelkar, S., Muley, S., Ambardekar, P. (2019). Commonly Asked Questions. In: Towards Optimal Management of Diabetes in Surgery. Springer, Singapore. https://doi.org/10.1007/978-981-13-7705-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7705-1_13

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7704-4

  • Online ISBN: 978-981-13-7705-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation